Applied Proteomics DiscernDx to Use Applied Proteomics Assets to Explore New Dx Approaches Premium The API assets could enable more data-intensive, machine learning-based approaches to healthcare, said a principal at DiscernDx investor Khosla Ventures. Applied Proteomics Sells Assets to DiscernDx for $1.85M DiscernDx, which is backed by Khosla Ventures, stepped in to purchase API's assets after lender Square 1 Bank asserted a lien on the company late last year. Applied Proteomics Looking to Outsource Sales Operations, Expand Assay Development Premium The firm is looking for outside partners to tackle test commercialization as it begins to bring its second-generation colorectal cancer assay to market. Applied Proteomics Releasing Second-Gen Colon Cancer Test; Exploring Dried Blood Spots Premium The test, which the company aims to launch in the next few months, offers a boost in specificity compared to its existing SimpliPro Colon proteomic test. Applied Proteomics Encouraged by Early Sales of CRC Test Premium Company officials said that they have seen favorable reorder rates and coverage decisions since launching the 11-protein colorectal cancer test in late 2015. Jun 26, 2015 Applied Proteomics Prepping ELISA Version of CRC Test for Near-Term Release Premium Oct 9, 2013 Applied Proteomics, DKFZ to Collaborate on Cancer MDx Aug 23, 2013 API Closes on $28M Round Supporting Development of Colorectal Test, Biomarker Discovery Efforts Premium Aug 23, 2013 People in the News: Thomas Bachmann, Joseph Eggler, and More Premium Aug 20, 2013 Applied Proteomics Closes $28M Series C Round Jun 28, 2013 Slow Sales Leave Some Proteomics Dx Firms Questioning Value of Large Clinical Lab Deals Premium May 10, 2013 GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic Premium Mar 29, 2013 Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay Premium Mar 7, 2013 Agilent, Applied Proteomics Partner on Development of Mass Spec-based Protein Assays Feb 10, 2012 Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery Premium Feb 10, 2012 People in the News: New Board Member, CEO at Applied Proteomics Premium Feb 7, 2012 Applied Proteomics Raises $22.5M, Moves to San Diego Dec 30, 2009 Applied Proteomics, ALS TDI Collaborating on Markers Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.